...
首页> 外文期刊>Recent patents on endocrine, metabolic & immune drug discovery >Correlation of Urine Biomarkers: Microalbuminuria and Spot Urine Protein among Diabetic Patients. Application of Spot Urine Protein in Diabetic Kidney Disease, Nephropatfay, Proteinuria Estimation, Diagnosing and Monitoring
【24h】

Correlation of Urine Biomarkers: Microalbuminuria and Spot Urine Protein among Diabetic Patients. Application of Spot Urine Protein in Diabetic Kidney Disease, Nephropatfay, Proteinuria Estimation, Diagnosing and Monitoring

机译:尿液生物标志物的相关性:糖尿病患者微量白蛋白尿和斑点尿蛋白。斑点尿蛋白在糖尿病肾病、肾病、蛋白尿估计、诊断和监测中的应用

获取原文
获取原文并翻译 | 示例

摘要

Current study has invented a new method for utilizing spot urine protein among diabetic patients. There have been various efforts and strategies in research internationally to detect, diagnose and monitor nephropathy/DKD. Although 24-hour urine studies are gold standard, however, there exist some controversies about microalbuminuria and spot urine protein. The current study was designed to utilize spot urine protein among diabetic patients and to find its association with routine dipstick urine test for albumin, and microalbuminuria. The study demonstrated significant association of spot urine protein with urine dipstick albumin, and has demonstrated increasing spot urine protein with increasing albumin in urine (p-value < 0.0001). This study also demonstrated significantly higher levels of spot urine protein between the groups with nephropathy/DKD as compared to those without nephropathy/DKD (p-value < 0.0001). Similarly, spot urine protein and spot urine protein/creatinine were also significantly associated with microalbumin and microalbumin/creatinine in urine. Significant regression models for spot urine protein and microalbuminuria were also developed and proposed to detect and estimate microalbumin in urine while utilizing spot urine protein (< 0.0001). Synthesized regression equations and models can be used confidently to detect, rule out and monitor proteinuria and DKD. ROC curves were utilized to detect spot urine protein cutoff points for nephropathy and DKD with high specificity and sensitivity. Some important patents were also discussed in the paper regarding albuminuria/proteinuria detection and management. Current study has demonstrated and concluded, for the first time, that there exists a significant association of spot urine protein with routine dipstick albumin in urine and microalbuminuria. It is also essential to detect early, monitor and manage proteinuria, hypertension and dyslipidemia with good glycemic control to prevent diabetes complications.
机译:目前的研究发明了一种在糖尿病患者中利用斑点尿蛋白的新方法。国际上在检测、诊断和监测肾病/DKD 方面的研究已经有了各种努力和策略。尽管 24 小时尿液检查是金标准,但关于微量白蛋白尿和斑点尿蛋白存在一些争议。本研究旨在利用糖尿病患者的斑点尿蛋白,并发现其与常规试纸尿液检测白蛋白和微量白蛋白尿的关联。该研究证明了斑点尿蛋白与尿试纸白蛋白的显著相关性,并证明了斑点尿蛋白的增加与尿液中白蛋白的增加(p 值 < 0.0001)。该研究还表明,与无肾病/DKD 组相比,肾病/DKD 组的斑点尿蛋白水平显着更高(p 值 < 0.0001)。同样,尿液中的斑点尿蛋白和斑点尿蛋白/肌酐也与尿液中的微量白蛋白和微量白蛋白/肌酐显著相关。还开发了斑点尿蛋白和微量白蛋白尿的显着回归模型,并提出了在利用斑点尿蛋白(< 0.0001)时检测和估计尿液中的微量白蛋白。合成的回归方程和模型可以自信地用于检测、排除和监测蛋白尿和 DKD。ROC曲线检测肾病和DKD的斑点尿蛋白临界点,特异性和灵敏度高。论文中还讨论了一些关于白蛋白尿/蛋白尿检测和管理的重要专利。目前的研究首次证明并得出结论,尿液中的斑点尿蛋白与常规试纸白蛋白和微量白蛋白尿存在显着关联。早期发现、监测和管理蛋白尿、高血压和血脂异常以及良好的血糖控制对于预防糖尿病并发症也很重要。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号